All Journals > Infection Control and Hospital Epidemiology > November 2007 > Infection Control and Hospital‐Acquired MRSA Infection

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

November 2007

Volume 28, Number 11
Infect Control Hosp Epidemiol 2007;28:1261–1266
0899-823X/2007/2811-0008$15.00
DOI: 10.1086/521658
Original Article

Impact of Contact and Droplet Precautions on the Incidence of Hospital‐Acquired Methicillin‐Resistant Staphylococcus aureus Infection

Ed Mangini, RN, MPH, CIC;

Sorana Segal‐Maurer, MD;

Janice Burns, RN, CIC;

Annette Avicolli, PharmD;

Carl Urban, PhD;

Noriel Mariano, MS;

Louise Grenner, BA;

Carl Rosenberg, PhD;

James J. Rahal, MD

From the Departments of Medicine (S.S.‐M., J.J.R., A.A.) and Microbiology (C.U.), Weill Cornell Medical College, New York, the Infectious Diseases Section of the Department of Medicine (E.M., N.M., L.G.) and the Department of Nursing (J.B.), New York Hospital Medical Center of Queens, Flushing, and Taro Pharmaceuticals, Hawthorne (C.R.), New York.

Objective.To evaluate the efficacy of contact and droplet precautions in reducing the incidence of hospital‐acquired methicillin‐resistant Staphylococcus aureus (MRSA) infections.

Design.Before‐after study.

Setting.A 439‐bed, university‐affiliated community hospital.

Methods.To identify inpatients infected or colonized with MRSA, we conducted surveillance of S. aureus isolates recovered from clinical culture and processed by the hospital's clinical microbiology laboratory. We then reviewed patient records for all individuals from whom MRSA was recovered. The rates of hospital‐acquired MRSA infection were tabulated for each area where patients received nursing care. After a baseline period, contact and droplet precautions were implemented in all intensive care units (ICUs). Reductions in the incidence of hospital‐acquired MRSA infection in ICUs led to the implementation of contact precautions in non‐ICU patient care areas (hereafter, “non‐ICU areas”), as well. Droplet precautions were discontinued. An analysis comparing the rates of hospital‐acquired MRSA infection during different intervention periods was performed.

Results.The combined baseline rate of hospital‐acquired MRSA infection was 10.0 infections per 1,000 patient‐days in the medical ICU (MICU) and surgical ICU (SICU) and 0.7 infections per 1,000 patient‐days in other ICUs. Following the implementation of contact and droplet precautions, combined rates of hospital‐acquired MRSA infection in the MICU and SICU decreased to 4.3 infections per 1,000 patient‐days (95% confidence interval [CI], 0.17‐0.97; ). There was no significant change in hospital‐acquired MRSA infection rates in other ICUs. After the discontinuation of droplet precautions, the combined rate in the MICU and SICU decreased further to 2.5 infections per 1,000 patient‐days. This finding was not significant ( ). In the non‐ICU areas that had a high incidence of hospital‐acquired MRSA infection, the rate prior to implementation of contact precautions was 1.3 infections per 1,000 patient‐days. After the implementation of contact precautions, the rate in these areas decreased to 0.9 infections per 1,000 patient‐days (95% CI, 0.47‐0.94; ).

Conclusion.The implementation of contact precautions significantly decreased the rate of hospital‐acquired MRSA infection, and discontinuation of droplet precautions in the ICUs led to a further reduction. Additional studies evaluating specific infection control strategies are needed.

Received March 16, 2007; accepted June 14, 2007; electronically published September 18, 2007.

Address reprint requests to Ed Mangini, RN, Infectious Diseases Section, Department of Medicine, New York Hospital Medical Center of Queens, 56‐45 Main Street, Flushing, NY 11355 ().

Cited by

John M. Boyce. (2008) Editorial Commentary: Community‐Associated Methicillin‐Resistant Staphylococcus aureus as a Cause of Health Care–Associated Infection. Clinical Infectious Diseases 46:6, 795-798
Online publication date: 15-Mar-2008.
  • Presented in part: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; Washington, DC; December 16‐19, 2005 (Abstract K545/416).

Close Popup